Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs
- 30 September 2006
- journal article
- Published by Elsevier BV in Respiratory Medicine
- Vol. 100 (9), 1566-1572
- https://doi.org/10.1016/j.rmed.2006.01.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Action of Fluoroquinolones and Linezolid on Logarithmic- and Stationary-Phase Culture of Mycobacterium tuberculosisChemotherapy, 2004
- Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studiesClinical Therapeutics, 2004
- Programmes and principles in treatment of multidrug-resistant tuberculosisThe Lancet, 2004
- A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicityBritish Journal of Dermatology, 2003
- Comparative Roles of Levofloxacin and Ofloxacin in the Treatment of Multidrug-Resistant TuberculosisChest, 2003
- The global situation of MDR-TBTuberculosis, 2003
- Studies of the Early Bactericidal Activity of New Drugs for TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapyEuropean Respiratory Journal, 2001
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000